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In preceding papers  (1)  it has been shown that mice and rabbits 
may acquire a high degree of immunity, following repeated inhalations 
of living pneumococci.  In this work it was shown that the strain of 
Type  I  pneumococcus used  produced a  high mortality among the 
exposed rabbits and that many of the survivors have agglutinins and 
protective antibodies in their serum.  In the present study it seemed 
interesting to determine the immunity response to less virulent strains. 
For this purpose a  Type II pneumococcus was used.  Pneumococcus 
Type II, however, is relatively avirulent for rabbits.  One strain was 
transformed into the "R" form by repeated transfers in antipneumo- 
coccus Type II serum.  The changes to the "R" form are accompanied 
by  loss  of  capsule,  type specificity, and  virulence.  This  strain  is 
referred to as Pneumococcus  IIR.  The stock culture of Pneumococcus 
Type II would cause a fatal septicemia in rabbits when injected intra- 
peritoneally in doses of at least 0.1 cc.  This strain is called Pneumo- 
coccus Type II (SAy).  By repeated animal passages the virulence of 
this strain was raised so that an intraperitoneal injection of 0.000,01 cc. 
of broth culture would regularly kill rabbits.  This virulent culture is 
designated as Pneumococcus Type II (Sv). 
It has already been shown that rabbits are only susceptible to fatal 
infection by inhalations of virulent Type II pneumococci (Sv)  (2). 
Although pneumococcus septicemia may be caused in an occasional 
rabbit  following inhalation  of  the  slightly  virulent  Pneumococcus 
Type II, death does Irot ensue.  In the present paper is reported the 
development of  (1)  agglutinins  and  (2)  protective  antibodies  in 
the blood serum of rabbits  following repeated inhalations of aviru- 
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lent liP,,  slightly virulent Type II (SAv), and virulent Type II (Sv) 
pneumococci. 
Method 
Rabbits were placed in a large spray chamber similar to that already described 
(3) and exposed to a spray of pneumococci.  50 cc. of an 8 hour broth culture were 
used for each spraying.  The animals were exposed at 10 day intervals.  Before 
each spraying, a sample of blood was obtained from the ear vein of each animal. 
None of the normal rabbit sera contained agglufinlus nor did the normal sera pro- 
tect mice against intraperitoneal injections  of 0.000,001  cc.  of Type II pneu- 
mOCOCCUS. 
10 days after each exposure the presence of agglutinins in the serum of exposed 
animals was determined by a modified thread reaction.  To 1 cc. of rabbit serum 
diluted in normal salt solution was added 0.2 cc. of an actively growing broth cul- 
ture of Pneumococcus Type II.  The tubes were incubated for 2 hours in the 
water bath at 37°C., placed in the ice box overnight, and the reactions read the 
next morning.  Agglutinlus were recorded as present in the serum only when the 
reactions were positive in a dilution of at least 1 : 10. 
The presence of protective antibodies in the blood of the sprayed rabbits was 
determined by the ability of 0.2 cc. of serum to protect white mice against intra- 
peritoneal  injection  of 0.001 cc.  of  Pneumococcus  Type II  culture, of which 
0.000,001 cc. killed a normal mouse within 48 hours.  The rabbit serum and cul- 
ture were administered simultaneously. 
Pneumococcus I I R 
Of the I7 rabbits which were sprayed from 1 to  10 times  with "R" 
forms derived from Type II pneumococcus none died from pneumo- 
coccus  septicemia.  Not  even the  8  rabbits  which  were  exposed  l0 
successive  times  developed  any  demonstrable  agglutinins  for  Type 
II  pneumococcus. 
Neither  did  the  sera of any of these rabbits  protect mice  against 
intraperitoneal injections of 0.001 cc. of a virulent culture of Pneumo- 
coccus Type II.  As is seen from Table I  the sera of these 5 animals, 
however, showed evidence of slight protection as demonstrated by the 
presence of a  low  degree of protective antibodies.  Even  the  slight 
amount of protection afforded by these sera is not constant. 
Pneumococcus Type ff (SAy) 
Of 11  rabbits sprayed from 1 to 10 times with the slightly virulent 
Pneumococcus  Type II (SAy), none  died  from pneumococcus  septi- ERNEST  G.  STILLMABI  227 
cemia.  Not even the 8 rabbits which had completed the whole course 
of  10  exposures  developed  any  demonstrable  agglutinins  for  Type 
II  pneumococcus. 
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First Appearance and Degree of Protection Following Repeated Exposure to 
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TExT-FIa.  1.  Comparison of presence of protective antibodies and agglutinins 
in rabbits following repeated inhalations of slightly virulent Type II (SAy) pneu- 
mococci. 
........  per cent of rabbits showing agglutinins in serum following spraying. 
per cent of rabbits showing protective antibodies in their serum. 228  AGGLUTININS  AND  PROTECTIVE  ANTIBODIES 
Protective Antibodies 
In Table II is shown the number of rabbits which were repeatedly 
sprayed from 1 to  10 times with Pneumococcus Type II  (SAv)  and 
the number thus exposed of which the serum subsequently protected 
mice against intraperitoneal injection of 0.001  co. of a virulent culture 
of Type II pneumococcus.  From this table it is seen that protective 
antibodies were demonstrable in the sera of i  of the rabbits after the 
1st  spray.  Following  each  successive  spraying,  the percentage  of 
TABLE  II 
Number of Rabbits Exposed to Pneumococcus II (SAy) and Number Yielding Serum 
Which Protected Mice against 0.001 Cc. of Pneumococcus Type II 
No.  ...........  of exposures ............................  1  2  3  4  5  6  7  8  9  10 
NO. of rabbits .....................  } 11  I  10  I  10  I  10  I  10  I  10  I  10  I  10  I  9  I  8 
......  whose  serum protected.I -- ]  11  4 I  5 I  4 t  6[  6]  9 t  8 I  7 
Per cent of rabbits whose serum pro- 
tected ..........................  [  --[  10  I  40  I  50  I  40  I  60  I  60  I  90  I  88[  87 
TABLE  III 
First Appearance  of Protective Antibodies  in the Serum of Rabbits 
Exposed to Inhalation  of Pneumococd Type II (SAy) 
o. of spray ......  1  2  3  4  5  6  7  8  9  10 
[O. of rabbits showing protective an- 
tibodies ......  --  1  3  1  1  1  1  1 
rabbits  showing  protection  steadily  increased,  until  after  the  8th 
spraying the serum of 90  per cent of the animals conferred passive 
protection on mice against at least 1000 lethal doses of virulent cul- 
tures.  The development of protective antibodies is graphically shown 
in  Text-fig.  1.  The  exposure following which the rabbit  sera first 
protected mice is shown in Table III.  From this it is seen that with 
each successive spray the number of rabbits in the sera of which protec- 
tive antibodies were demonstrable progressively increased.  Certain 
rabbits showed protective antibodies only after the 7th or 8th exposure. ERNEST G.  STILLMAN  229 
Pneumococcus II (Sv) 
Of 50 rabbits sprayed from 1 to  10 times with the virulent strain  of 
Type II (Sv) pneumococcus, 12 or 24 per cent  died  of pneumococcus 
septicemia after the first exposure.  As the more susceptible animals 
succumbed early, serum was obtained only from rabbits with the greatest 
natural resistance, individuals which had also acquired a  certain degree 
of immunity, as the result of repeated exposures to live  pneumococci. 
TABLE  IV 
Relation of Development of A gglutinins to tke Number of Exposures to Rabbit Virulent 
Pneumococcus II (Sv) 
...........  10  No. of exposures ............................  I  2  3  4  5  6  7  8  9 
No. of rabbits .....................  38  34  32  29  23  22  21  17  16  15 
......  showingagglutinins  .... I  3]  3[  2  I  2  I  2  I  2]  2  I  2  I  21  2 
Per centofrabbitsshowingagglufi-I  ]  I  ]  ]  I  ]  I  ]  I 
nins ............................  l  71  81  61  61  41  91  9111112113 
TABLE  V 
First Appearance and Titre of Agglutinim Following Repeated Inhalations of Rabbit 
Virulent  Pneumococcus Type II  (Sv) 
Fo o.,_  oxoo ure__:  ._______,  __21_3  ±  --8 9-- ,o 
Rabbitl ........................  11-201-- I  --  {-- I-- r--I--  I-- [--[-- 
|  ! 
"  2  ........................  11-1o11-1o]  -  i1-1o]- 11-1o11-1o[1-2o[1-4olv4o 
"  3  .......................  I1-1011-s011-200.  I  I  I  I  I  I  I 
"  4 ................  S .......  I -  11-2°11-2°  L1-5°11-4°11-I°11-1°11-1°11-1°11-I° 
--, no agglufinins demonstrable in serum. 
* Accidental death of rabbit following  3rd exposure. 
In Table IV is shown the number of rabbits which were sprayed 
from 1 to 10 times whose serum showed agglutinins in dilutions of at 
least 1 to 10.  From Table IV it is seen that 3 or 7 per cent of the 38 
rabbits  which  survived  the  first  exposure  developed  demonstrable 
agglutinins. 
Only 4  rabbits  developed agglutinins.  In  Table  V are shown the 
exposures after which agglufinins first appeared and the titre of agglu- 230  AGGLUTININS  AND  PROTECTIVE  ANTIBODIES 
tinins  following  each  subsequent  spraying.  Three  rabbits  showed 
agglutinins after the first exposure.  Following the initial appearance 
of the agglufinins there is a tendency for the fitre to rise after subse- 
quent exposures.  But in one instance the agglutinins disappeared, 
and in another became less marked. 
Protective A ntibodies 
In Table VI are shown the number of rabbits that were sprayed from 
1 to 10 times with rabbit virulent Pneumococcus II (Sv) and the num- 
TABLE  VI 
Number  of Rabbits  Exposed  to Rabbit  Virulent Pneumococcus  Type II  (Sv)  and 
Number That Developed Protective Antibodies in Their Serum 
No. of exposures  ............................  i  2  3  4  5  6  7  8  9  10 
No. of rabbits .....................  1381341  32  I 29  123122  I 21  I  17  I  16115 
......  whose  serumprotected.  I  6}  7 I  7 I  7[41414  I  61618 
Per cent of rabbits whose serum pro-  I 
tected  ..........................  I  10l  20121  1241171  18[29135}37  I 53 
TABLE  VII 
First Appearance of Protective Antibodies 
No. of spray ................................  1  2  3  4  5  6  7  8  9  10 
..........  i  .........  6  ,  I-  ,  -  -  - 
ber thus  expose.d  the  serum of which subsequently protected mice 
against intraperitoneal injections of 0.001  cc. of a virulent culture of 
Type II (Sv) pneumococcus.  From this table it is seen that protec- 
tive antibodies were demonstrable in the sera of 4 or 10 per cent of the 
rabbits  after the 1st spray.  Following each successive spraying the 
number of rabbits yielding serum which conferred passive protection 
increased, until after the 10th spraying the serum of 8 or 53 per cent 
of the animals conferred passive protection on mice against at least 
1000 lethal doses of virulent culture.  The spray following which the 
sera first protected mice is shown in Table VII. ERNEST G. STILLMAN  231 
From Table VII it is seen that after the 1st exposure the sera of 6 
rabbits  showed  protective  antibodies.  After  successive  sprays  an 
occasional rabbit would first show protective antibodies.  Protective 
substances were first demonstrated in the sera of 3 rabbits only after 
the  10th exposure. 
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TExT-FIG. 2.  Comparison of mortality and presence of protective antibodies 
and agglutinins in rabbits following  repeated inhalations of virulent Type II (Sv) 
pneumococci. 
per cent of rabbits dying with pneumococcus septicemia following 
successive sprayings. 
........  per cent of rabbits showing  agglutinins in serum following  spraying. 
per cent of rabbits showing  protective antibodies in their serum. 
Correlation of A gglutinins and Protective Antibodies 
It is difficult to compare the relative titre of the sera at any one time 
because of the difference in the standards used.  Whereas agglufinins 
were recorded as positive if present in serum concentration of 1 : 10, pro- 
tective antibodies were noted only if they were present in concentra- 
tions sufficient to protect mice against a 0.001 cc. of virulent pneumo- 
coccus culture.  If smaller doses of pneumococcus had been used, the 232  AGGLUTININS AND PROTECTIVE ANTIBODIES 
presence of protective antibodies would  undoubtedly have been de- 
tected earlier and the incidence of their occurrence would have been 
more frequent.  However, when these antibodies were demonstrable 
under the conditions of this experiment, their presence was evidence 
of the capacity of the serum to confer a  high degree of passive im- 
munity on mice. 
In 3 instances both agglutinins and protective antibodies occurred 
after the same spray; in another rabbit, yielding serum that contained 
agglutinins,  protective antibodies appeared after the next exposure. 
In 9  instances protective antibodies occurred without demonstrable 
agglutinins in the serum and the sera of 7 rabbits, even after 10 expo- 
sures, contained no agglutinins or protective antibodies even sufficient 
to protect mice against 0.000,001  of a virulent Type II pneumococcus. 
The relative occurrence of agglutinins and of protective antibodies 
in the serums of rabbits following inhalations of rabbit virulent strain 
of Type II  (Sv)  pneumococcus is graphically shown in Text-fig. 2. 
In this figure the mortality curve of rabbits dying from pneumococcus 
septicemia is also given.  It is seen that after the 1st exposure 24 per 
cent of the rabbits  died from pneumococcus septicemia.  An occa- 
sional rabbit  died following subsequent exposures.  The sera of the 
rabbits  dying after the 3rd,  5th  and 6th exposures showed neither 
agglutinins nor protective antibodies.  The serum of the rabbit dying 
after the 10th spray, however, protected mice against 0.01 cc. of pneu- 
mococcus culture.  It is unfortunate that it is not known if the pneu- 
mococcus recovered from this  rabbit  was the original type specific 
organism used for spraying or a degenerated "R" form.  The number 
of rabbits  that developed agglutinins was never great, nor was the 
titre high.  The proportion of rabbits showing agglutinins rose only 
slightly following successive exposures.  On the other hand, there was 
a distinct tendency for the proportion of rabbits to develop protective 
antibodies with each successive spray.  Following the 10th  exposure 
53 per cent of the total number of survivals showed the presence of 
these immune substances in their serum. 
DISCUSSION 
Although too few rabbits were used to  give as definite results as 
after spraying with Type I  pneumococcus, some definite results are ERNEST  G.  STILLMAN  233 
indicated.  It  appears  that  the immunological reactions of rabbits 
following inhalations of the same type of pneumococci vary in direct 
proportion to the virulence of the organism.  In the case of exposure 
to a non-virulent degenerated "R" strain derived from Type II pneu- 
mococcus no type specific antibody response was elicited.  If rabbits 
are allowed to inhale slightly virulent Type II (SAv) pneumococcus, 
none  succumb  to  infection,  although  a  certain  number  develop a 
pneumococcus  septicemia.  As the result of successive spraying a large 
proportion of the animals developed protective antibodies in  their 
serum but no agglutinins.  Following the initial exposure to a rabbit- 
virulent Pneumococcus Type II (Sv) the greatest number of rabbits 
succumbed to a  fatal septicemia.  Certain rabbits developed a high 
degree of immunity as evidenced  by the presence of agglutinin and pro- 
tective antibodies in their serum.  Why a larger proportion of rabbits 
exposed to the slightly virulent Pneumococcus Type II (SAv) devel- 
oped  protective  antibodies  than  those  sprayed  with  the  virulent 
Pneumococcus Type II (Sv) is difficult to explain.  The reaction of 
the rabbits to inhalations of the virulent Type II (Sv) culture parallels 
the results obtained when rabbits were sprayed with a rabbit-virulent 
Type I  pneumococcus. 
From the foregoing experiments it is certain that following  inhalation 
of living virulent pneumococci of Type I or II rabbits develop a high 
degree of immunity.  This immunity is probably induced by a  few 
organisms penetrating the respiratory epithelium and entering into 
the body tissues.  It has already been shown that rabbits may recover 
from  a  transient  pneumococcus septicemia following inhalation  of 
pneumococci.  The great variations both in the time of first appear- 
ance and in the final titre of ~mmune bodies are difficult to explain. 
Among the factors which cannot be experimentally controlled are: 
first, the number of organisms which come to lodge within the respira- 
tory tract following exposure to a bacterial spray; second, the number 
which are able to invade the tissues after implantation; and third, the 
final  disposition of these bacteria  in  the animal body.  In  certain 
instances the multiplication of the invading organisms goes on un- 
checked until the death of the animal.  In others a  transient carrier 
state may occur with subsequent immunity responses.  It is certainly 
significant that whereas the curve of incidence of protective antibodies 234  AGGLUTININS AND  PROTECTIVE ANTIBODIES 
steadily increases, the percentage of rabbits showing agg|utinins does 
not materially change after the 5th spraying. 
CONCLUSIONS 
1.  Following repeated inhalations of the degeneratcd non-virulent 
"R" forms of Type II pneumococcus, no type specific antibodies can 
be demonstrated in the serum of rabbits. 
2.  Following  repeated  inhalations  of  slightly  virulent  Type  II 
(SAv) pneumococci,  only protective antibodies can be demonstrated in 
the serum of rabbits. 
3.  Following repeated inhalations of virulent Type II (Sv) pneumo- 
cocci, agglutinins and protective antibodies can be demonstrated in 
the serum of rabbits. 
4.  Following repeated exposures of rabbits to inhalation of pneumo- 
cocci, the type specific response, evidenced by type specific protective 
antibodies and agglutinins, varies in direct proportion to the virulence 
of the culture used. 
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